Johnson Matthey PLC (LON:JMAT – Get Free Report) has received an average recommendation of “Moderate Buy” from the six analysts that are presently covering the firm, Marketbeat.com reports. Two research analysts have rated the stock with a hold rating and four have given a buy rating to the company. The average twelve-month target price among analysts that have covered the stock in the last year is GBX 2,218.33.
JMAT has been the subject of several research reports. UBS Group restated a “neutral” rating and set a GBX 2,200 price target on shares of Johnson Matthey in a report on Friday. Berenberg Bank dropped their price objective on shares of Johnson Matthey from GBX 2,250 to GBX 2,100 and set a “buy” rating on the stock in a research note on Monday, March 23rd. Finally, Deutsche Bank Aktiengesellschaft lifted their target price on shares of Johnson Matthey from GBX 1,922 to GBX 2,120 and gave the company a “buy” rating in a research note on Tuesday, April 7th.
Check Out Our Latest Stock Analysis on JMAT
Johnson Matthey Stock Up 2.7%
Insider Activity at Johnson Matthey
In other news, insider Liam Condon purchased 14 shares of the business’s stock in a transaction dated Wednesday, March 11th. The stock was bought at an average cost of GBX 1,941 per share, with a total value of £271.74. Also, insider Alastair Judge purchased 14 shares of Johnson Matthey stock in a transaction dated Wednesday, April 15th. The shares were purchased at an average price of GBX 2,022 per share, with a total value of £283.08. Over the last 90 days, insiders bought 10,434 shares of company stock valued at $20,144,228. Insiders own 0.51% of the company’s stock.
Johnson Matthey Company Profile
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources. Today more than 13,000 Johnson Matthey professionals collaborate with their network of customers and partners to make a real difference to the world around us.
Read More
- Five stocks we like better than Johnson Matthey
- Lowe’s Finds Support at $215 After Q1 Earnings Sell-Off
- Deere Beats Q2 Estimates, But Ag Weakness Weighs on Outlook
- Overextended, e.l.f. Beauty Is Primed to Rebound in Back Half
- Biogen Stock Slides After Trial Miss, But Analysts Stay Bullish
Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.
